Skip to main content

Peer Review reports

From: Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux

Original Submission
8 Mar 2018 Submitted Original manuscript
25 Apr 2018 Author responded Author comments - Judith Offman
Resubmission - Version 2
25 Apr 2018 Submitted Manuscript version 2
10 Jul 2018 Editorially accepted
3 Aug 2018 Article published 10.1186/s12885-018-4664-3

You can find further information about peer review here.

Back to article page